RecruitingNCT03568630

Blood Markers of Early Pancreas Cancer

A Longitudinal Cohort Study to Identify Clinical and Blood Markers of Early Pancreas Cancer


Sponsor

University of Nebraska

Enrollment

1,250 participants

Start Date

Jul 26, 2018

Study Type

OBSERVATIONAL

Conditions

Summary

Identifying biomarkers of early pancreatic ductal adenocarcinoma (PDAC) could facilitate screening for individuals at higher than average risk and expedite the diagnosis in individuals with symptoms and substantially improve an individual's chance of surviving the disease. The investigators propose a longitudinal study of subjects at higher than average risk of PDAC in order to generate clinical data and bank serial blood specimens.


Eligibility

Min Age: 19 Years

Plain Language Summary

Simplified for easier understanding

This study looks for early blood markers (measurable signs in a blood test) that could help detect pancreatic cancer at an earlier, more treatable stage, especially in people who are at higher risk. **You may be eligible if...** - You are 19 years of age or older - You are able to attend in-person visits in Omaha, Nebraska twice a year for blood samples - You fall into one or more high-risk groups, such as: newly diagnosed type 2 diabetes or high-risk pre-diabetes within the past 3 years, a family history of pancreatic cancer, a known genetic mutation linked to pancreatic cancer risk, or a history of chronic pancreatitis **You may NOT be eligible if...** - You are under 19 years old - You are unable to attend in-person visits in Omaha twice a year - You do not meet the criteria for any of the defined risk cohorts Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Unversity of Nebraska Medical Center

Omaha, Nebraska, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03568630


Related Trials